424 related articles for article (PubMed ID: 27382053)
1. Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration.
Feng X; Liu P; Zhou X; Li MT; Li FL; Wang Z; Meng Z; Sun YP; Yu Y; Xiong Y; Yuan HX; Guan KL
J Biol Chem; 2016 Sep; 291(36):18947-58. PubMed ID: 27382053
[TBL] [Abstract][Full Text] [Related]
2. Arterial stiffness induces remodeling phenotypes in pulmonary artery smooth muscle cells via YAP/TAZ-mediated repression of cyclooxygenase-2.
Dieffenbach PB; Haeger CM; Coronata AMF; Choi KM; Varelas X; Tschumperlin DJ; Fredenburgh LE
Am J Physiol Lung Cell Mol Physiol; 2017 Sep; 313(3):L628-L647. PubMed ID: 28642262
[TBL] [Abstract][Full Text] [Related]
3. The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP.
Kimura TE; Duggirala A; Smith MC; White S; Sala-Newby GB; Newby AC; Bond M
J Mol Cell Cardiol; 2016 Jan; 90():1-10. PubMed ID: 26625714
[TBL] [Abstract][Full Text] [Related]
4. Fibulin-5 promotes airway smooth muscle cell proliferation and migration via modulating Hippo-YAP/TAZ pathway.
Fu J; Zheng M; Zhang X; Zhang Y; Chen Y; Li H; Wang X; Zhang J
Biochem Biophys Res Commun; 2017 Nov; 493(2):985-991. PubMed ID: 28942149
[TBL] [Abstract][Full Text] [Related]
5. Arterial Wall Stress Induces Phenotypic Switching of Arterial Smooth Muscle Cells in Vascular Remodeling by Activating the YAP/TAZ Signaling Pathway.
Wang Y; Cao W; Cui J; Yu Y; Zhao Y; Shi J; Wu J; Xia Z; Yu B; Liu J
Cell Physiol Biochem; 2018; 51(2):842-853. PubMed ID: 30466081
[TBL] [Abstract][Full Text] [Related]
6. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.
Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA
J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639
[TBL] [Abstract][Full Text] [Related]
7. Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species.
Wilson SJ; Cavanagh CC; Lesher AM; Frey AJ; Russell SE; Smyth EM
J Lipid Res; 2009 Jun; 50(6):1047-56. PubMed ID: 19151335
[TBL] [Abstract][Full Text] [Related]
8. Activation of thromboxane A(2) receptors induces orphan nuclear receptor Nurr1 expression and stimulates cell proliferation in human lung cancer cells.
Li X; Tai HH
Carcinogenesis; 2009 Sep; 30(9):1606-13. PubMed ID: 19570744
[TBL] [Abstract][Full Text] [Related]
9. The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ.
Edwards DN; Ngwa VM; Wang S; Shiuan E; Brantley-Sieders DM; Kim LC; Reynolds AB; Chen J
Sci Signal; 2017 Dec; 10(508):. PubMed ID: 29208682
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane A2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen.
Grosser T; Zucker TP; Weber AA; Schulte K; Sachinidis A; Vetter H; Schrör K
Eur J Pharmacol; 1997 Jan; 319(2-3):327-32. PubMed ID: 9042608
[TBL] [Abstract][Full Text] [Related]
11. Thromboxane A2 (TP) receptor in the non-pregnant porcine myometrium and its role in regulation of spontaneous contractile activity.
Cao J; Wakatsuki A; Yoshida M; Kitazawa T; Taneike T
Eur J Pharmacol; 2004 Feb; 485(1-3):317-27. PubMed ID: 14757156
[TBL] [Abstract][Full Text] [Related]
12. A new family of thromboxane receptor antagonists with secondary thromboxane synthase inhibition.
Pace-Asciak CR; Reynaud D; Demin P; Aslam R; Sun A
J Pharmacol Exp Ther; 2002 May; 301(2):618-24. PubMed ID: 11961065
[TBL] [Abstract][Full Text] [Related]
13. Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer.
Ando T; Charindra D; Shrestha M; Umehara H; Ogawa I; Miyauchi M; Takata T
Oncogene; 2018 Jan; 37(2):263-270. PubMed ID: 28925394
[TBL] [Abstract][Full Text] [Related]
14. Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade.
Pfister SL; Pratt PE; Kurian J; Campbell WB
Vascul Pharmacol; 2004 Jan; 40(6):285-92. PubMed ID: 15063832
[TBL] [Abstract][Full Text] [Related]
15. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
16. TIAM1 Antagonizes TAZ/YAP Both in the Destruction Complex in the Cytoplasm and in the Nucleus to Inhibit Invasion of Intestinal Epithelial Cells.
Diamantopoulou Z; White G; Fadlullah MZH; Dreger M; Pickering K; Maltas J; Ashton G; MacLeod R; Baillie GS; Kouskoff V; Lacaud G; Murray GI; Sansom OJ; Hurlstone AFL; Malliri A
Cancer Cell; 2017 May; 31(5):621-634.e6. PubMed ID: 28416184
[TBL] [Abstract][Full Text] [Related]
17. Actin like-6A promotes glioma progression through stabilization of transcriptional regulators YAP/TAZ.
Ji J; Xu R; Zhang X; Han M; Xu Y; Wei Y; Ding K; Wang S; Bin Huang ; Chen A; Di Zhang ; Jiang Z; Xu S; Zhang Q; Li W; Ni S; Wang J; Li X
Cell Death Dis; 2018 May; 9(5):517. PubMed ID: 29725063
[TBL] [Abstract][Full Text] [Related]
18. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
Masuda A; Mais DE; Oatis JE; Halushka PV
Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482
[TBL] [Abstract][Full Text] [Related]
19. Hippo pathway-independent restriction of TAZ and YAP by angiomotin.
Chan SW; Lim CJ; Chong YF; Pobbati AV; Huang C; Hong W
J Biol Chem; 2011 Mar; 286(9):7018-26. PubMed ID: 21224387
[TBL] [Abstract][Full Text] [Related]
20. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
Zhu J; Wu T; Lin Q
Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
